Helix Biostructures

Helix Biostructures is a contract research organization providing drug discovery services to the pharmaceutical industry. 

As part of the recommendation, HCN consultants investigated the following:

1. Creating a market research report of Helix's main service lines taking into account competitor landscape, pricing, market size, market growth, trends, and other relevant factors

2. Creating a market research report for Helix's new software product

3. Providing a recommendation for a market penetration strategy for Helix's new software product

​

To begin the project, HCN Consultants conducted a SWOT analysis to determine the current state of Helix Biostructures.

​

Next, our consultants looked at cost-based, competitor-based, and value-based pricing strategies to find the best fit for Helix. They determined that it would be best to price the SaaS and service segments differently to better address the market with their proprietary technology. Both should have a cost-based structure as the underlying factor to generate revenue from the good/service.

​

Our research on the competitive landscape in the pharmaceutical research services industry indicated high fragmentation with low market share concentration. Small, niche specialty companies like Helix competed against a few high-profile companies. Key success factors included access to a highly skilled workforce, a good reputation, the ability to adapt to new technologies, well-developed internal processes, and an understanding of government policies. The major players in the industry offered end-to-end drug development services, supporting clients through and after the clinical trial process. Thus, smaller companies like Helix would need to compete on price, faster turnaround times, increased specialization, and increased customer focus.

​

Finally, our team of consultants conducted extensive research on the use of cloud storage for Helix's drug discovery process. We found that clients expect increased efficiency, reduced costs, and acceleration of the research and development process for their drug when utilizing cloud computing and storage for their data.

​

Our research identified that a positive reputation is crucial for the success of the cloud within the pharmaceutical research services industry. Our consultants recommend that Helix upholds this positive reputation by ensuring that its cloud service protects files when in use, in transit, and storage by encrypting them, so that only the client has control and access to the files.

​

Lastly, we found that utilizing cloud data for data comparisons can help drug developers see where they stand amongst competitors, allowing them to develop drugs that outperform existing products. Comparative clinical trials are not feasible, making cloud data comparison an increasingly essential tool in the drug development process. Overall, our consultants recommend that Helix implement these key success factors to fully utilize the benefits of cloud storage in their drug discovery process.